Search Results - "Wiersma, S R"

Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity by MINEISHI, S, LONGO, W. L, ATKINSON, M. E, SMITH, E. P, HAMIELEC, M, WIERSMA, S. R, KINSELLA, T. J, SCHUENING, F. G

“…The optimal conditioning regimen for allogeneic BMT for hematological malignancies is still to be determined. We used a conditioning regimen including…”
Get full text

Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group by Barnard, D R, Kalousek, D K, Wiersma, S R, Lange, B J, Benjamin, D R, Arthur, D C, Buckley, J D, Kobrinsky, N, Neudorf, S, Sanders, J, Miller, L P, Shina, D C, Hammond, G D, Woods, W G

“…The purposes of this report are to reaffirm concordance difficulties with the acute myeloid leukemia (AML) French-American-British (FAB) classification, to…”
Get more information

Clinical Importance of Myeloid-Antigen Expression in Acute Lymphoblastic Leukemia of Childhood by Wiersma, Susan R, Ortega, Jorge, Sobel, Eugene, Weinberg, Kenneth I

“…ACUTE lymphoblastic leukemia (ALL) is a clonal expansion of cells committed to differentiation as either B or T lymphocytes. These cells retain the…”
Get full text

Musculoskeletal neoplasms: preoperative evaluation with MR angiography by Swan, J S, Grist, T M, Sproat, I A, Heiner, J P, Wiersma, S R, Heisey, D M

“…To assess the ability of magnetic resonance (MR) angiography to depict vascularity of musculoskeletal neoplasms. Two-dimensional (2D) time-of-flight (TOF) MR…”
Get more information

Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1 by Maris, John M., Wiersma, Susan R., Mahgoub, Nidal, Thompson, Patricia, Geyer, Russell J., Hurwitz, Carole G. H., Lange, Beverly J., Shannon, Kevin M.

“…BACKGROUND Children with neurofibromatosis type 1 (NF1) are at increased risk of developing benign and malignant solid tumors as well as hematologic…”
Get full text

Fludarabine and Cytarabine as a Sequential Infusion Regimen for Treatment of Adults with Recurrent, Refractory or Poor Prognosis Acute Leukemia by Vidarsson, Brynjar, Abonour, Rafat, Williams, Eliot C., Woodson, Robert D., Turman, Nancy J., Kim, Kyungmann, Mosher, Deane F., Wiersma, Susan R., Longo, Walter L.

“…We did a retrospective analysis on the safety and efficacy of sequential infusion fludarabine and cytosine arabinoside (ara-C) in treating refractory,…”
Get full text

Progressive Langerhans cell histiocytosis in an infant with Klinefelter syndrome successfully treated with allogeneic bone marrow transplantation by FROST, J. D, WIERSMA, S. R

“…We describe successful treatment of an infant with progressive Langerhans cell histiocytosis (LCH) with allogeneic bone marrow transplantation (BMT), and…”
Get full text

Treatment of wilms' tumour. Current recommendations by MEHTA, M. P, BASTIN, K. T, WIERSMA, S. R

“…Wilms' tumour (nephroblastoma, renal embryoma) is the fifth most common paediatric malignancy, arising from the embryonal tissue of kidneys and first formally…”
Get full text